Related Experiment Video
Updated: Jun 2, 2026

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Priapism in sickle-cell disease: a hematologist's perspective.
1National Heart, Lung and Blood Institute, National Institutes of Health-Sickle Cell Vascular Disease Section, Cardiovascular and Pulmonary Branch, Bethesda, MD 20892-1476, USA. gkato@mail.nih.gov
Priapism in sickle cell disease (SCD) is linked to hemolysis, impacting nitric oxide and adenosine pathways. Current treatments are questioned, favoring early intervention and further research into these signaling mechanisms.
Area of Science:
- Hematology
- Urology
- Vascular Biology
Background:
- Priapism is a known complication of sickle cell disease (SCD) and other hemolytic anemias.
- Understanding the mechanisms of priapism in SCD is crucial for effective management.
Purpose of the Study:
- To provide urologists with a comprehensive review of priapism in SCD from a hematologist's perspective.
- To highlight current understanding and challenges in SCD-related priapism.
Main Methods:
- Literature search of Medline using terms priapism, erectile dysfunction, and sickle cell through July 2010.
- Expert opinion based on medical literature review.
Main Results:
- Priapism risk in SCD correlates with intravascular hemolysis severity.
- Hemolysis may reduce nitric oxide bioavailability and dysregulate penile adenosine signaling.
- Efficacy of traditional treatments is questioned, with growing support for early aspiration and irrigation.
Conclusions:
- Limited evidence supports medical prophylaxis for recurrent priapism in SCD.
- Nitric oxide and adenosine signaling pathways warrant further investigation.
- Multidisciplinary collaboration between hematologists and urologists is essential for managing sickle cell priapism.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Multiple Allele Traits
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
